- Home
- TLX vs CMC Comparison
TLX vs CMC Comparison
Compare TLX & CMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- CMC
- Stock Information
- Founded
- TLX 2015
- CMC 1915
- Country
- TLX Australia
- CMC United States
- Employees
- TLX N/A
- CMC N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- CMC Steel/Iron Ore
- Sector
- TLX Health Care
- CMC Industrials
- Exchange
- TLX Nasdaq
- CMC Nasdaq
- Market Cap
- TLX 5.7B
- CMC 5.5B
- IPO Year
- TLX N/A
- CMC 1987
- Fundamental
- Price
- TLX $17.15
- CMC $48.68
- Analyst Decision
- TLX Strong Buy
- CMC Buy
- Analyst Count
- TLX 2
- CMC 8
- Target Price
- TLX $22.00
- CMC $59.14
- AVG Volume (30 Days)
- TLX 24.4K
- CMC 1.0M
- Earning Date
- TLX 01-01-0001
- CMC 06-23-2025
- Dividend Yield
- TLX N/A
- CMC 1.48%
- EPS Growth
- TLX 798.14
- CMC N/A
- EPS
- TLX 0.09
- CMC 0.63
- Revenue
- TLX $484,687,790.00
- CMC $7,738,612,000.00
- Revenue This Year
- TLX N/A
- CMC N/A
- Revenue Next Year
- TLX N/A
- CMC $8.14
- P/E Ratio
- TLX $189.97
- CMC $76.92
- Revenue Growth
- TLX 55.85
- CMC N/A
- 52 Week Low
- TLX $13.61
- CMC $37.92
- 52 Week High
- TLX $30.36
- CMC $64.53
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- CMC 53.41
- Support Level
- TLX N/A
- CMC $47.92
- Resistance Level
- TLX N/A
- CMC $49.95
- Average True Range (ATR)
- TLX 0.00
- CMC 1.23
- MACD
- TLX 0.00
- CMC -0.16
- Stochastic Oscillator
- TLX 0.00
- CMC 23.72
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About CMC Commercial Metals Company
Commercial Metals Co operates steel mills, steel fabrication plants, and metal recycling facilities in the United States and manufactures rebar and structural steel, which are key product categories for the nonresidential construction sector. The Company has three operating and reportable segments: North America Steel Group, Europe Steel Group and Emerging Businesses Group.